[Federal Register Volume 71, Number 32 (Thursday, February 16, 2006)]
[Notices]
[Page 8304]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E6-2235]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Office of the Secretary


Findings of Research Misconduct

AGENCY: Office of the Secretary, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Notice is hereby given that on January 13, 2006, the 
Department of Health and Human Services (HHS) Debarring Official, on 
behalf of the Secretary of HHS, issued a final notice of debarment 
based on the research misconduct findings of the U.S. Public Health 
Service (PHS) in the following case:
    April Swe, University of Wisconsin-Madison: Based on the report of 
an investigation conducted by the University of Wisconsin-Madison (UWM) 
and additional analysis conducted by the Office of Research Integrity 
(ORI) in its oversight review, PHS found that Ms. Swe, former graduate 
student at UWM, engaged in research misconduct by fabricating data on 
thirty-nine (39) questionnaires of sibling human subjects associated 
with an autism study. The research was supported by National Institute 
on Aging, National Institutes of Health (NIH), grant R01 AG08768.
    In a final decision dated January 13, 2006, the HHS Debarring 
Official, on behalf of the Secretary of HHS, issued the final debarment 
notice based on the PHS findings of research misconduct. The following 
administrative actions have been implemented for a period of three (3) 
years, beginning on January 13, 2006:
    (1) Ms. Swe has been debarred from eligibility for or involvement 
as a principal in nonprocurement transactions (e.g., grants and 
cooperative agreements) of the Federal Government and from contracting 
or subcontracting with any Federal Government agency, except as 
provided in 45 CFR 76.120. This action is being taken pursuant to the 
debarment regulations at 45 CFR part 76.
    (2) Ms. Swe has been prohibited from serving in any advisory 
capacity to PHS including but not limited to service on any PHS 
advisory committee, board, and/or peer review committee, or as 
consultant.

FOR FURTHER INFORMATION CONTACT: Director, Division of Research 
Investigations, Office of Research Integrity, 1101 Wootton Parkway, 
Suite 750, Rockville, MD 20852, (240) 453-8800.

Chris B. Pascal,
Director, Office of Research Integrity.
[FR Doc. E6-2235 Filed 2-15-06; 8:45 am]
BILLING CODE 4160-17-P